ARIA México 2014. Adaptación de la Guía de Práctica Clínica ARIA 2010 para México. Metodología ADAPTE

Autor: José Luis Mayorga-Butrón, Fernando Iduñate-Palacios, Marco Antonio Figueroa-Morales, Luis Xochihua-Díaz, Désirée Larenas-Linnemann, Lorenzo Curiel-Aceves, Gabriel Montes-Narváez, Miguel Alejandro Medina-Ávalos, Andrés Sánchez-González, Rodrigo Vásquez del Mercado-Cordero, Carlos García-Bolaños, María del Carmen Cano-Salas, José Antonio Sacre-Hazouri, Liliana Velasco-Hidalgo, Alfredo Arias-Cruz, César Virgen-Ortega, Juan José Luis Sienra-Monge, María Antonia Rivera-Gómez, Ambrocio Aguilar-Aranda, Marcos Alejandro Jiménez-Chobillon, Doris N López-Lizárraga, Margarita Fernández-Vega, Miguel A Betancourt-Suárez, Raúl Humberto Barnica-Alvarado, Jorge Olvera-Salinas, Blanca Estela Del Río-Navarro, Héctor Hernán-Ruiz, Sergio Jesús Romero-Tapia, Jorge Salas-Hernández, Cecilia Solís-Galicia, Arturo Ramírez-García, Héctor Stone-Aguilar, Javier Dibildox-Martínez, Juan José Matta-Campos
Rok vydání: 2014
Předmět:
Zdroj: Revista Alergia México. 61:S3-116
ISSN: 2448-9190
0002-5151
Popis: Background: The global prevalence of allergic rhinitis is high. International Study of Asthma and Allergies in Childhood (ISAAC) Phase III reports a total estimated prevalence of 4.6% in Mexico. There is evidence based on allergic rhinitis Clinical Practice Guidelines (CPG), but its promotion, acceptance and application is not optimal or adequate in Mexico. Objective: To generate a guideline for the treatment of allergic rhinitis and its impact on asthma by adaptating the 2010 ARIA Guideline to Mexican reality, through a transculturation process applying the ADAPTE methodology. Material and method: Using the ADAPTE Methodology, the original 2010 ARIA CPG recommendations were evaluated by the guideline development group (GDG) into which multiple medical specialities managing patients with allergic rhinitis were incoorporated. The GDG valorated the quality of 2010 ARIA, checked and translated key clinical questions. Moreover, the GDG adjusted recommendations, patient preferences and included comments in the context of the Mexican reality (safety, costs and cultural issues). To accomplish this, we ran Delphi panels with as many rounds as necessary to reach agreement. One extra question, not included in the original 2010 ARIA, on the use of Nasal Lavages for AR was created sustained by a systematic literature review. Results: A total of 45 questions from the original 2010 ARIA were included and divided into six groups covering prevention, medical treatment, immunotherapy and alternative medicine to treat patients with allergic rhinitis with or without asthma. Most of the questions reached agreement in one or two rounds; one question required three rounds. Conclusions: An easy-to-use, adaptated, up-to-date and applicable allergic rhinitis guideline for Mexico is now available.
Databáze: OpenAIRE
Externí odkaz: